GetTopicDetailResponse(id=77569e1855, topicName=Ilaris, introduction=Ilaris, content=null, image=null, comments=3, allHits=1059, url=https://h5.medsci.cn/topic?id=9718, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=11206, tagList=[TagDto(tagId=11206, tagName=Ilaris)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2003302, encodeId=eb0a20033028d, content=<a href='/topic/show?id=77569e1855' target=_blank style='color:#2F92EE;'>#Ilaris#</a>, objectTitle=諾華的Ilaris無法降低COVID-19患者的死亡率, objectType=article, longId=203010, objectId=f0a3203010db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0a3203010db, replyNumber=0, likeNumber=77, createdTime=2021-06-02, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0a3203010db, moduleTitle=諾華的Ilaris無法降低COVID-19患者的死亡率, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f0a3203010db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003301, encodeId=6e802003301b2, content=<a href='/topic/show?id=77569e1855' target=_blank style='color:#2F92EE;'>#Ilaris#</a>, objectTitle=重磅！FDA一次性批準(zhǔn)諾華抗炎藥Ilaris 3個(gè)新的適應(yīng)癥, objectType=article, longId=79021, objectId=679ce902173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=679ce902173, replyNumber=0, likeNumber=95, createdTime=2016-12-12, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=679ce902173, moduleTitle=重磅！FDA一次性批準(zhǔn)諾華抗炎藥Ilaris 3個(gè)新的適應(yīng)癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=679ce902173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003300, encodeId=7614200330062, content=<a href='/topic/show?id=77569e1855' target=_blank style='color:#2F92EE;'>#Ilaris#</a>, objectTitle=FDA批準(zhǔn)諾華旗下Ilaris用于治療兒童關(guān)節(jié)炎, objectType=article, longId=18702, objectId=236418e0263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236418e0263, replyNumber=0, likeNumber=0, createdTime=2014-04-06, rootId=0, userName=xzw113, userId=2317301, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236418e0263, moduleTitle=FDA批準(zhǔn)諾華旗下Ilaris用于治療兒童關(guān)節(jié)炎, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=236418e0263)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
